medigraphic.com
Instituto Nacional de Salud Pública

2020, Number 6

<< Back Next >>

salud publica mex 2020; 62 (6)

Depressive symptoms and coverage of diagnosis and treatment of depression in Mexican population

Cerecero-García D, Macías-González F, Arámburo-Muro T, Bautista-Arredondo S

Language: Spanish
References: 28
Page: 840-850
PDF size: 976.80 Kb.


ABSTRACT

Objective. To assess changes in the prevalence of depressive symptoms (DS) and in detection and treatment coverage between 2006 and 2018, and to identify the sociodemographic factors associated with the latter. Materials and methods. We used data from the Ensanut 2006, 2012, 2018-19, 100k. We used logistic regression to explore demographic factors associated with coverage of detection and treatment of depression. Results. The prevalence of DS was respectively: 15.4, 13.7, 13.6 and 15.0%. Living in municipalities with a very high and high degree of marginalization was associated with less coverage of detection and treatment of depression. Conclusions. This work provides evidence on the gaps that exist in access to mental health services between regions and different levels of marginalization and highlights the need to direct efforts to increase access to health services that allow timely diagnosis and treatment of DS and depression.


REFERENCES

  1. Organización Mundial de la Salud, Organización Panamericana de la Salud. Depresión y otros trastornos mentales comunes. Estimaciones sanitarias mundiales [internet]. Ginebra: OMS/OPS, 2017 [citado mayo 11, 2020]. Disponible en: https://iris.paho.org/bitstream/handle/ 10665.2/34006/PAHONMH17005-spa.pdf?sequence=1&isAllowed=y

  2. Organización Mundial de la Salud . The Global Burden of Disease: 2004 update [internet]. Ginebra: OMS, 2008 [citado mayo 11, 2020]. Disponible en: https://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pdf?ua=1

  3. Institute for Health Metrics and Evaluation, The Lancet. Findings from the Global Burden of Disease Study 2017 [internet]. Washington: IHME/The Lancet, 2018 [citado mayo 11, 2020].Disponible en: http://www.healthdata. org/sites/default/files/files/policy_report/2019/GBD_2017_Booklet.pdf

  4. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291(21):2581-90. https://doi.org/10.1001/jama.291.21.2581

  5. Kessler RC, Angermeyer M, Anthony JC, De Graaf R, Demyttenaere K, Gasquet I, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry. 2007;6(3):168-76.

  6. Belló M, Puentes-Rosas E, Medina-Mora ME, Lozano R. Prevalencia y diagnóstico de depresión en población adulta en México. Salud Publica Mex. 2005;47(supl 1):4-11.

  7. De Castro F, Place JM, Villalobos A, Allen-Leigh B. Sintomatología depresiva materna en México: Prevalencia nacional, atención y perfiles poblacionales de riesgo. Salud Publica Mex. 2015;57(2):144-54. https://doi. org/10.21149/spm.v57i2.7410

  8. Franco-Díaz KL, Fernández-Niño JA, Astudillo-García CI. Prevalencia de síntomas depresivos e invarianza factorial de la escala de Depresión del Centro de Estudios Epidemiológicos (CES-D) en población indígena mexicana. Biomedica. 2018;38(supl 1):127-40. https://doi.org/10.7705/ biomedica.v38i0.3681

  9. World Health Organization. Depression [internet]. Ginebra: WHO, 2020 [citado mayo 11, 2020]. Disponible en: https://www.who.int/health-topics/ depression#tab=tab_1

  10. Sartorius N, Üstün TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: Results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl. 1996;168(supl 30):38-43. https://doi.org/10.1192/S0007125000298395

  11. Gater R, De Almeida E Sousa B, Barrientos G, Caraveo J, Chandrashekar CR, Dhadphale M, et al. The pathways to psychiatric care: A crosscultural study. Psychol Med. 1991;21(3):761-74. https://doi.org/10.1017/ s003329170002239x

  12. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J, Fleiz C, et al. Prevalence, service use, and demographic correlates of 12-month DSMIV psychiatric disorders in Mexico: Results from the Mexican National Comorbidity Survey. Psychol Med. 2005;35(12):1773-83. https://doi. org/10.1017/S0033291705005672

  13. Palma O, Shamah-Levy T, Franco A, Olaiz-Fernández G, Méndez-Ramírez I. Metodología. En: Olaiz-Fernaìndez G, Rivera-Dommarco J, Shamah- Levy T, Rojas R, Villalpando-Hernaìndez S, Hernaìndez-Avila M, Sepúlveda J. (eds). Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006: 19-33 [citado mayo 11, 2020]. Disponible en: https://ensanut.insp.mx/encuestas/ensanut2006/doctos/ informes/ensanut2006.pdf

  14. Romero-Martínez M, Shamah-Levy T, Franco-Núñez A, Villalpando S, Cuevas-Nasu L, Gutiérrez JP, Rivera-Dommarco JÁ. Encuesta Nacional de Salud y Nutrición 2012: Diseño y cobertura. Salud Publica Mex. 2013;55(supl 2):332-40. https://doi.org/10.21149/spm.v55s2.5132

  15. Romero-Martínez M, Shamah-Levy T, Vielma-Orozco E, Heredia-Hernández O, Mojica-Cuevas J, Cuevas-Nasu L, Rivera-Dommarco J. Encuesta Nacional de Salud y Nutrición 2018-19: metodología y perspectivas. Salud Publica Mex. 2019;61(6):917-23. https://doi.org/10.21149/11095

  16. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Gaona-Pineda EB, Gómez-Acosta LM, Mendoza-Alvarado LR, et al. Metodología de la Encuesta Nacional de Salud y Nutrición para localidades con menos de 100 000 habitantes (Ensanut 100k). Salud Publica Mex. 2019;61(5):678-84. https://doi.org/10.21149/10539

  17. Salinas-Rodríguez A, Manrique-Espinoza B, Acosta-Castillo I, Téllez- Rojo MM, Franco-Núñez L A, Gutiérrez-Robledo LM, Sosa-Ortiz AL. Validación de un punto de corte para la Escala de Depresión del Centro de Estudios Epidemiológicos, versión abreviada (CESD-7). Salud Publica Mex. 2013;55(3):267-74. http://doi.org/10.21149/spm.v55i3.7209

  18. Guze SB. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Am J Psychiatry. 1995;152(8):1228. https://doi.org/10.1176/ ajp.152.8.1228

  19. Consejo Nacional de Población. Índice de marginación por entidad federativa y municipio 2015 [internet]. Ciudad de México: Conapo, 2016 [citado mayo 11, 2020]. Disponible en: https://www.gob.mx/conapo/documentos/ indice-de-marginacion-por-entidad-federativa-y-municipio-2015

  20. Cohen A, Chapman BP, Gilman SE, Delmerico AM, Wieczorek W, Duberstein PR, Lyness JM. Social inequalities in the occurrence of suicidal ideation among older primary care patients. Am J Geriatr Psychiatry. 2010;18(12):1146-54. https://doi.org/10.1097/JGP.0b013e3181dd1e55

  21. Cohen A, Gilman SE, Houck PR, Szanto K, Reynolds CF. Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiatry Psychiatr Epidemiol. 2009;44(4):272-7. https://doi.org/10.1007/s00127-008-0436-8

  22. Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA. Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471-81. https://doi.org/10.1017/S0033291712001511

  23. Medina-Mora ME, Borges G, Lara Muñoz C, Benjet C, Blanco Jaimes J, Fleiz Bautista C, et al. Prevalencia de trastornos mentales y uso de servicios: Resultados de la Encuesta Nacional de-Epidemiología Psiquiátrica en México. Salud Ment. 2003;26(4):1-16.

  24. Araya R, Zitko P, Markkula N, Rai D, Jones K. Determinants of access to health care for depression in 49 countries: A multilevel analysis. J Affect Disord. 2018;234:80-8. https://doi.org/10.1016/j.jad.2018.02.092

  25. Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, et al. Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry. 2008;192(5):368-75. https:// doi.org/10.1192/bjp.bp.107.039107

  26. Alonso J, Buron A, Bruffaerts R, He Y, Posada-Villa J, Lepine JP, et al. Association of perceived stigma and mood and anxiety disorders: Results from the World Mental Health Surveys. Acta Psychiatr Scand. 2008;118(4):305-14. https://doi.org/10.1111/j.1600-0447.2008.01241.x

  27. Borges G, Wang PS, Medina-Mora ME, Lara C, Chiu WT. Delay of first treatment of mental and substance use disorders in Mexico. Am J Public Health. 2007;97(9):1638-43. https://doi.org/10.2105/AJPH.2006.090985

  28. Dohrenwend BP, Shrout PE, Egri G, Mendelsohn FS. Nonspecific psychological distress and other dimensions of Psychopathology: Measures for use in the general population. Arch Gen Psychiatry. 1980;37(11):1229-36. https://doi.org/10.1001/archpsyc.1980.01780240027003




2020     |     www.medigraphic.com